Le Lézard
Classified in: Health
Subject: SVY

Injectable Drug Delivery: A 2-Day Seminar Presented by Experts (London, UK - March 18-19, 2020)

DUBLIN, Jan. 27, 2020 /PRNewswire/ -- The "Injectable Drug Delivery" conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This seminar has been designed to provide all those working in the industry with the latest information on the next generation of injectable drugs and devices and an update on recent trends, technologies and applications. It will also be a great opportunity to meet industry leaders, as well as like-minded professionals, and share common experience and best practice.

Attending this two-day seminar, presented by experts in the field, will:

Injectable drug delivery is considered to be one of the most effective routes of administration due to the speed and effectiveness of delivery to the target, and recent developments have improved the patient experience.

The global injectable drug delivery market continues to grow and technology is advancing. This, coupled with the ever-changing regulatory requirements, means that it is imperative for companies to stay abreast of the latest developments and challenges within the industry in order to remain compliant, as well as gaining a competitive edge.


Programme Day One

Devices, technology, and latest trends

Latest developments for injectable drug delivery solutions

Recent advances in large-volume injection

Discussion session

Developments in technology with injectables - digitalisation and smart technology

Digital design in the development of injectable systems

Discussion session

Case study: Connected needle-free technology

Patient considerations and design processes

Assessing injection site pain

Discussion session

Betwixt and between - managing the interface between PFS and autoinjector

Interactive panel discussion: Next-generation innovations in drug delivery
Moderator: Dr Gregory Berman
Panellists: Ian Thompson, Neil Williams, Markus Bauss, Dr Thomas Schoenknecht

Drinks reception

Programme Day Two

Regulatory update and human factors

The EU regulatory framework for injectable delivery systems

Human factors validation - when is usability testing not required?

Discussion session

Sustainability - its impact on self-care drug delivery

Packaging and quality

Extractables and leachables (E&L) in injectable drug products

Discussion session

Pre-filled syringes in a nutshell

The relationship between the ICH guidelines for impurities and E&L thresholds

Interactive panel discussion: The future with smart injection devices
Moderator: Dr Gregory Berman
Panellists: Ian Thompson and Dr Thomas Schoenknecht

Chair's closing remarks

For more information about this conference visit https://www.researchandmarkets.com/r/umvzr6

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

These press releases may also interest you

at 11:23
Mohan Giridharadas and Sanjeev Agrawal of LeanTaaS today announced the publication of Better Healthcare Through Math: Bending the Access and Cost Curves in Healthcare. The book is published with ForbesBooks, the exclusive business book publishing...

at 11:22
On September 28, JIECANG celebrated its 20th anniversary in JIECANG Life and Health Industrial Park in Zhejiang. With its customer-centric strategy, strong product customization capabilities and production capacity, two decades of focus in linear...

at 11:15
A petition calling on the UK government to prepare a Challenge Study Center capable of housing 100-200 volunteers for a potential COVID-19 human challenge trial has gained the support of prominent British intellectuals including Lord Ara Darzi, Nobel...

at 11:10
Surgical Innovation Associates (SIA), an early growth-stage medical technology company, announced today it secured CE Mark approval for its flagship absorbable mesh, DuraSorb®. The product provides mechanical support and scaffolding during the early...

at 11:05
bioAffinity Technologies, a privately held biotech company, today announced Martin Tammemägi, PhD, Professor Emeritus of Health Sciences at Brock University, will serve as Chairman of the bioAffinity Scientific and Medical Advisory (SMA) Board. "Dr....

at 11:05
Trio Health, a leading technology provider of real-world data and insights on patients announces the launch of the first-ever Patient Voice database in Rheumatology to acknowledge and incorporate the voice of the patient in access programs, clinical...

News published on 27 january 2020 at 18:15 and distributed by: